Clinical Trials Directory

Trials / Unknown

UnknownNCT01182831

Trial Comparing Two Techniques of Celiac Plexus Neurolysis for Treatment of Pain in Carcinoma Pancreas

A Randomized Trial Comparing Fluoroscopy Guided Percutaneous Technique Versus Endoscopic Ultrasound Guided Technique of Celiac Plexus Neurolysis for Treatment of Pain in Carcinoma Pancreas

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Asian Institute of Gastroenterology, India · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Coeliac plexus neurolysis (CPN) is a management option for pain control in carcinoma pancreas.CPN is conventionally performed by percutaneous technique with fluoroscopic guidance. Endoscopic ultrasound (EUS) is increasingly used for CPN as it offers a better visualization of the plexus. There are limited data comparing the two modalities.The patients are on follow-up for 6 months post neurolysis.

Detailed description

Carcinoma pancreas patients with abdominal pain requiring daily analgesics for more than 4 weeks were included.we are randomising about 100 patients into two groups to undergo either of the two procedures, i.e. celiac plexus neurolysis by percutaneous technique or by endoscopic ultrasound guided technique.The pain scores have been recorded by visual analogue scale for an average follow-up of 6 months.

Conditions

Interventions

TypeNameDescription
PROCEDUREpercutaneous fluoro guided celiac plexus neurolysisIt is percutaneous injection of neurolytic agent in and around the celiac ganglion
PROCEDUREEUS guided neurolysisIt is injection of neurolytic agent in and around the celiac ganglion using an echo endoscope.

Timeline

Start date
2010-01-01
Primary completion
2011-01-01
Completion
2011-01-01
First posted
2010-08-17
Last updated
2010-08-30

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT01182831. Inclusion in this directory is not an endorsement.

Trial Comparing Two Techniques of Celiac Plexus Neurolysis for Treatment of Pain in Carcinoma Pancreas (NCT01182831) · Clinical Trials Directory